Related Experiment Video

Updated: Aug 30, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

[Juvenile idiopathic arthritis and uveitis: screening and anti-inflammatory therapy]

Arnd Heiligenhaus1, Anne Mingels, Ulrich Neudorf

  • 1Augenabteilung am St.-Franziskus-Hospital, Muenster. arnd.heiligenhaus@t-online.de

Klinische Monatsblatter Fur Augenheilkunde
|November 25, 2003
PubMed

Insights

This article reviews childhood rheumatic diseases, focusing on juvenile idiopathic arthritis and uveitis. It compares classifications and details anti-inflammatory treatments and prognostic factors for visual health.

Area of Science:

  • Pediatric Rheumatology
  • Ophthalmology
  • Immunology

Context:

  • Rheumatic diseases in childhood present complex diagnostic and therapeutic challenges.
  • Juvenile idiopathic arthritis (JIA) is a significant cause of chronic childhood arthritis.
  • Uveitis is a common and potentially sight-threatening complication of JIA.

Purpose:

  • To provide a comprehensive overview of childhood rheumatic diseases, emphasizing JIA and its ocular manifestations.
  • To compare current classification systems (EULAR, ACR, ILAR) for pediatric rheumatic diseases.
  • To review the pathogenesis, epidemiology, diagnosis, clinical course, and treatment of uveitis in JIA.

Summary:

  • The article details the characteristics of uveitis in various forms of arthritis, evaluating prognostic factors for its manifestation and visual loss.
  • It discusses anti-inflammatory medical treatments and regimens for uveitis in JIA.
  • Recommendations from the "uveitis in childhood study group" for screening and treatment, alongside a description of nationwide patient documentation, are presented.

Impact:

  • Improved understanding of JIA-associated uveitis can lead to earlier diagnosis and intervention.
  • Standardized screening and treatment protocols can mitigate visual impairment in affected children.
  • Nationwide documentation facilitates research and enhances patient care coordination.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...